John R. Mabus - Concepedia

Author

John R. Mabus

Johnson & Johnson (United States)

Also Known As

J Mabus, J. R. Mabus, John Mabus, John R Mabus, John R. Mabus, j. mabus

Publications

574

Citations

H-Index

Concepts

All Affiliations

Johnson & Johnson (United States)Janssen (United States)Springhouse

About

John R. Mabus is an author at Johnson & Johnson (United States) specializing in medicine, immunology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	282
2	Biochemistry	2	2	102
3	Health Sciences	1	1	23
4	Natural Sciences	1	1	79
5	Allergy	1	1	29

John R. Mabus

Publications

565

Citations

H-Index

Page 1

	Year	Citations
Microbiota‐derived tryptophan indoles increase after gastric bypass surgery and reduce intestinal permeability in vitro and in vivo Matthew Jennis, Cassandre Cavanaugh, Gregory C. Leo, Neurogastroenterology & Motility	2017	164
Alternative functional in vitro models of human intestinal epithelia Amanda L. Kauffman, Alexandra Gyurdieva, John R. Mabus, Frontiers in Pharmacology Alternative FunctionalInduced Pluripotent Stem CellImmunologyGastroenterologyPrimary Hinepcs	2013	108
Potent, Cell Active, Non-Thiol Tetrapeptide Inhibitors of Farnesyltransferase John T. Hunt, Ving G. Lee, Katerina Leftheris, Journal of Medicinal Chemistry Bioorganic ChemistryPharmacotherapyChemical BiologyPharmaceutical ChemistryMolecular Pharmacology	1996	79
Human and Non-Human Primate Intestinal FcRn Expression and Immunoglobulin G Transcytosis Pamela J. Hornby, Philip Cooper, Connie Kliwinski, Pharmaceutical Research	2013	74
Contribution of FcRn binding to intestinal uptake of IgG in suckling rat pups and human FcRn-transgenic mice Connie Kliwinski, Philip Cooper, Robert A. Perkinson, American Journal of Physiology-Gastrointestinal and Liver Physiology ImmunohematologyImmunocytochemical TechniqueLaboratory ImmunologyIntestinal UptakeImmunodeficiencies	2012	29
Dynamic Mass Redistribution as a Means to Measure and Differentiate Signaling via Opioid and Cannabinoid Receptors Ellen E. Codd, John R. Mabus, Brian S. Murray, Assay and Drug Development Technologies Differentiate SignalingCellular PharmacologyExperimental PharmacologyMolecular PharmacologyCell Signaling	2011	23
Prokineticin-1 evokes secretory and contractile activity in rat small intestine PR Wade, Jeffrey M. Palmer, John R. Mabus, Neurogastroenterology & Motility	2009	19
Factors influencing anti-antibody enhancement of tumor targeting with antibodies in hamsters with human colonic tumor xenografts. R M Sharkey, John R. Mabus, D M Goldenberg PubMed ImmunologySa InjectionPathologyVeterinary ResearchImmunotherapeutics	1988	17
The contribution of cell surface FcRn in monoclonal antibody serum uptake from the intestine in suckling rat pups Philip Cooper, Connie Kliwinski, Robert A. Perkinson, Frontiers in Pharmacology	2014	15
Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluation Janet L. Ralbovsky, Joseph G. Lisko, Jeffrey M. Palmer, Bioorganic & Medicinal Chemistry Letters MedicineImmunologyReceptor AntagonistsMechanism Of ActionPharmacological Agent	2009	15

Page 1